Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Duerden

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Drug and Therapeutics Bulletin|August 30, 2018
What is the place for monitored dosage systems?Martin Duerden
BMJ (Clinical Research Ed.)|April 10, 2004
Secondary prevention for stroke and transient ischaemic attacks: PROGRESS is about reducing blood pressure, not promoting drugsMartin Duerden
International Journal of Clinical Practice|November 14, 2007
Absence of policy on how to use statins in England and Wales: do not let JBS2 fill the voidMartin Duerden
BMJ (Clinical Research Ed.)|August 14, 2010
From a cancer drug fund to value based pricing of drugsMartin Duerden
The New England Journal of Medicine|May 26, 2007
Prevention of death in COPDMartin Duerden
Lancet (London, England)|January 24, 2006
ASCOT-BPLAMartin Duerden
BMJ (Clinical Research Ed.)|April 16, 2005
Direct to consumer marketing: switch to over the counter can become indirect advertising directly to consumersMartin Duerden, Tom Walley
BMJ (Clinical Research Ed.)|May 17, 2003
Chronic obstructive pulmonary diseaseDavid Price, Martin Duerden
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|June 30, 2015
Cardiovascular risk assessment and lipid modification: NICE guidelineMartin Duerden, Norma O'Flynn, Nadeem Qureshi
European Journal of Hospital Pharmacy : Science and Practice|June 4, 2019
Deprescribing: a primary care perspectivePolly Duncan, Martin Duerden, Rupert A Payne
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Drug and Therapeutics Bulletin|August 30, 2018
What is the place for monitored dosage systems?Martin Duerden
BMJ (Clinical Research Ed.)|April 10, 2004
Secondary prevention for stroke and transient ischaemic attacks: PROGRESS is about reducing blood pressure, not promoting drugsMartin Duerden
International Journal of Clinical Practice|November 14, 2007
Absence of policy on how to use statins in England and Wales: do not let JBS2 fill the voidMartin Duerden
BMJ (Clinical Research Ed.)|August 14, 2010
From a cancer drug fund to value based pricing of drugsMartin Duerden
The New England Journal of Medicine|May 26, 2007
Prevention of death in COPDMartin Duerden
Lancet (London, England)|January 24, 2006
ASCOT-BPLAMartin Duerden
BMJ (Clinical Research Ed.)|April 16, 2005
Direct to consumer marketing: switch to over the counter can become indirect advertising directly to consumersMartin Duerden, Tom Walley
BMJ (Clinical Research Ed.)|May 17, 2003
Chronic obstructive pulmonary diseaseDavid Price, Martin Duerden
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|June 30, 2015
Cardiovascular risk assessment and lipid modification: NICE guidelineMartin Duerden, Norma O'Flynn, Nadeem Qureshi
European Journal of Hospital Pharmacy : Science and Practice|June 4, 2019
Deprescribing: a primary care perspectivePolly Duncan, Martin Duerden, Rupert A Payne
Pageof 2